The potential of Panax notoginseng against COVID-19 infection.
J Ginseng Res
; 2023 Apr 08.
Article
in English
| MEDLINE | ID: covidwho-2296668
ABSTRACT
The COVID-19 pandemic has changed the world and has presented the scientific community with unprecedented challenges. Infection is associated with overproduction of proinflammatory cytokines secondary to hyperactivation of the innate immune response, inducing a cytokine storm and triggering multiorgan failure and significant morbidity/mortality. No specific treatment is yet available. For thousands of years, Panax notoginseng has been used to treat various infectious diseases. Experimental evidence of P. notoginseng utility in terms of alleviating the cytokine storm, especially the cascade, and improving post-COVID-19 symptoms, suggests that P. notoginseng may serve as a valuable adjunct treatment for COVID-19 infection.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Year:
2023
Document Type:
Article
Affiliation country:
J.jgr.2023.04.002
Similar
MEDLINE
...
LILACS
LIS